Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

(2014) José Rodrigues Coura et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo

(2011) Denise da Gama Jaén Batista et al.   PLoS One

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease

(2011) Rodolfo Viotti et al.   PLoS Neglected Tropical Diseases

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

(2010) Frank Smithuis et al.   LANCET INFECTIOUS DISEASES

Combination therapy for visceral leishmaniasis

(2010) Johan van Griensven et al.   LANCET INFECTIOUS DISEASES

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

(2010) Margoth Moreno et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Ergosterol biosynthesis and drug development for Chagas disease

(2009) Julio A Urbina   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Buthionine Sulfoximine Has Anti-Trypanosoma cruzi Activity in a Murine Model of Acute Chagas' Disease and Enhances the Efficacy of Nifurtimox

(2008) M. Faundez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo

(2007) Livia Vivas et al.   ACTA TROPICA

Trypanosoma cruzi: Acute and long-term infection in the vertebrate host can modify the response to benznidazole

(2007) Sérgio Caldas et al.   EXPERIMENTAL PARASITOLOGY